SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001127602-20-015653
Filing Date
2020-05-06
Accepted
2020-05-06 17:14:15
Documents
1
Period of Report
2020-05-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 12777
  Complete submission text file 0001127602-20-015653.txt   14280
Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033 908-740-4000
Merck & Co., Inc. (Issuer) CIK: 0000310158 (see all company filings)

IRS No.: 221918501 | State of Incorp.: NJ | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Business Address
Nally Michael (Reporting) CIK: 0001763945 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-06571 | Film No.: 20853604